인공 장기 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Artificial Organs Market was valued at USD 35.3 billion in 2024 and is projected to register a 10% CAGR between 2025 and 2034. As medical technology advances, artificial organs are increasingly replacing, supporting, and enhancing biological functions, helping patients regain normalcy. The demand for these life-saving devices is surging as chronic illnesses and organ failure cases rise, intensifying the need for alternative solutions beyond traditional transplants. With a severe shortage of donor organs, artificial replacements offer a viable, long-term solution, significantly reducing dependency on organ donations. The integration of bioengineered materials and cutting-edge technologies is improving device longevity, compatibility, and efficiency, fostering wider adoption across healthcare facilities.

Continuous research and development efforts are propelling innovations in artificial organ design, allowing for improved functionality and better patient outcomes. Next-generation bioartificial organs, incorporating advanced biomaterials and regenerative medicine, are reshaping the market landscape. As 3D bioprinting technology gains momentum, the production of customized, patient-specific artificial organs is becoming more feasible, accelerating medical advancements. With increasing investments from healthcare companies and government bodies, the artificial organs industry is poised for substantial expansion over the next decade. The rising prevalence of chronic kidney disease, liver failure, and cardiovascular disorders is further intensifying the need for technologically advanced organ solutions, ensuring sustained market growth.

The market is segmented by organ type, including artificial kidneys, livers, lungs, pancreas, hearts, and other organs. Artificial kidneys held the largest market share, generating USD 19.6 billion in 2024. The rising incidence of kidney-related diseases is driving demand, leading to continuous advancements in renal care technologies. With a growing number of patients requiring treatment for chronic conditions, innovative artificial kidney solutions are emerging as essential medical interventions. Expanding treatment options and enhanced medical capabilities are ensuring steady market expansion.

Material segmentation includes silicon, plastic, steel, and other biomaterials. Silicon accounted for a 36.2% share in 2024 and is projected to reach USD 34.7 billion by 2034. Its superior flexibility, durability, and compatibility make it an ideal choice for manufacturing advanced prosthetics and medical implants. Increasing demand for high-performance biomaterials is contributing to its widespread usage in artificial organs. Improved patient outcomes and reduced rejection rates are strengthening market positioning, thus encouraging further research into next-generation materials. As technological innovations refine artificial organ designs, biocompatible materials like silicon continue to dominate the industry.

U.S. artificial organs market generated USD 11.7 billion in 2023 and is expected to reach USD 32.3 billion by 2034. Growing cases of chronic diseases are driving adoption, increasing the demand for advanced medical solutions. Rising organ failure rates are prompting medical institutions to invest in cutting-edge technologies. As the industry focuses on developing more efficient solutions, artificial organs are becoming an integral part of modern healthcare. Expanding research and improvements in manufacturing are accelerating industry growth, pushing key players to enhance production capabilities. With ongoing advancements, artificial organ adoption is set to increase, shaping the future of medical science and patient care.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Scarcity of organ donors globally
    • 3.2.1.2 Increasing incidence of organ failures
    • 3.2.1.3 Growing technological advancements
    • 3.2.1.4 Rising geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of artificial organs and procedures
    • 3.2.2.2 Risk of device failure and complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Organ Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Artificial kidney
• 5.3 Artificial liver
• 5.4 Artificial lungs
• 5.5 Artificial pancreas
• 5.6 Artificial heart
• 5.7 Other organ types

Chapter 6 Market Estimates and Forecast, By Material Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Silicon
• 6.3 Plastic
• 6.4 Steel
• 6.5 Other material types

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 ABIOMED
• 8.2 Berlin Heart
• 8.3 Boston Scientific
• 8.4 Cochlear
• 8.5 Edwards Lifesciences
• 8.6 Ekso Bionics
• 8.7 Jarvik Heart
• 8.8 Medtronic
• 8.9 SynCardia Systems
• 8.10 Zimmer Biomet